The key reasons of Russian genomic sequencing market inefficiency

Abstract

discover the restrictive factors and reveal the reasons of genomic
sequencing equipment operational inefficiency. Discussion: the year volume
of Russian genomic sequencing market is about RUR100 million and 15%
increases annually. Nevertheless, this modest level is very low comparing
to high-powered equipment quantity purchased by the Federal and private
laboratories and medical centers during recent five-seven years (~120 pcs
of equipment). The authors made good use of open sources and databases
as SPARK as well as special sell & purchases databases to discover the
matter. Results: some key market factors and reasons for inefficiency were
described as the result of this analytical investigation. We may define
the following as the cardinals: more than half of equipment standing idle
because of outdate (the most goods were purchased just all at once about
3-5 years ago); only a small extent of whole equipment quantity is really
up-to-date and cost effective; there’s a lack of well-trained personnel;
genomic techniques are mostly still low-integrated in medical diagnostics;
there’re not sufficient funds for whole life-cycle support and supplies.